The Duke Division of Surgical Oncology is dedicated to improving surgical treatment options. Through basic, translational, and clinical research, our faculty creates cutting-edge therapies and treatments. Our research program is strengthened by collaboration with institutes and labs with the Duke University Medical Center.
Learn details about research in each of our sections:
The Duke Cancer Institute has a team of leading medical experts who manage and treat pancreatic cancer. Our surgeons collaborate with colleagues from across the medical center to offer multidisciplinary care to our patients.
With a team consisting of surgical oncology, medical oncology, radiation oncology, gastroenterology, pathology, radiology, and nursing, our program is not only focused on standard-of-care treatments but also on innovative research in the realm of pancreatic cancer.
Our hope is to provide optimal care to patients with this disease as well as to provide them with hope of more effective therapies.
Duke is a leader in research for clinical and laboratory investigations that propel the practice of medicine forward. An important component of this success is the scientific work performed at Duke University Medical Center.
Duke Surgical Oncology is involved in research that aims to:
- Improve understanding of how cancer drugs work and develop better, more effective therapies.
- Create screening tools that identify cancer earlier.
- Advance surgical therapies used to treat cancers of all types.
The Duke Department of Surgery is an internationally recognized leader in laboratory and clinical investigation, receiving more than $44 million dollars of grant and award funding each year. Our patients have access to the latest developments in patient care through participation in carefully designed clinical trials.